Related Experiment Video
Updated: Feb 19, 2026

08:57
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
27.8K
Is Central Pontine Myelinolysis Reversible?
WMJ : Official Publication of the State Medical Society of Wisconsin
|November 3, 2017
Summary
Central pontine myelinolysis (CPM) is a rare neurological condition. Early recognition and rapid treatment, including hyponatremia reinduction, can lead to significant recovery in CPM patients.
Area of Science:
- Neurology
- Internal Medicine
Background:
- Central pontine myelinolysis (CPM) is a rare but serious neurological condition associated with significant morbidity and mortality.
- Prompt therapeutic interventions are crucial for improving patient outcomes and prognosis in CPM.
Observation:
- A case study of a 34-year-old male with a history of alcohol abuse presented with Parkinsonian symptoms.
- These symptoms emerged 13 days post-hospitalization following rapid correction of serum sodium levels.
Findings:
- The patient experienced significant improvement after reinduction of hyponatremia, methylprednisolone treatment, and/or plasmapheresis.
- This suggests that CPM may be reversible with timely and aggressive therapeutic strategies.
Implications:
- This case highlights the potential for reversibility of central pontine myelinolysis when diagnosed and treated promptly.
- Rapid initiation of therapeutic interventions can positively impact recovery and overall prognosis for CPM patients.

